The SHP-2 tyrosine phosphatase: Signaling mechanisms and biological functions

Cell Research

Volumn 10, Issue 4, 2000, Pages 279-288

  Qu, Cheng Kui ^a,b  

^a HOLLAND LABORATORY   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

SHP 1; SHP 2; Signal transduction

Indexed keywords

PHOSPHOPROTEIN; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE SHP 1; SIGNAL PEPTIDE; SRC HOMOLOGY 2 (SH2) DOMAIN CONTAINING PHOSPHATASES; SRC HOMOLOGY-2 (SH2) DOMAIN-CONTAINING PHOSPHATASES;

ANIMAL; GENETICS; HEMATOPOIETIC STEM CELL; METABOLISM; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; HEMATOPOIETIC STEM CELLS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; PHOSPHOPROTEINS; PROTEIN-TYROSINE-PHOSPHATASE; SHP1 PROTEIN TYROSINE PHOSPHATASE; SIGNAL TRANSDUCTION;

EID: 0034572534     PISSN: 10010602     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cr.7290055     Document Type: Review

References (65)

1. Hunter T. Signaling-2000 and beyond. Cell 2000; 100:113-27.
2. Tonks NK and BG Neel. From form to function: signaling by protein tyrosine phosphatases. Cell 1996; 87:365-8.
3. Denu JM, JA Stuckey, MA Saper, JE Dixon. Form and function in protein dephosphorylation. Cell 1996; 87:361-4.
4. Feng GS, CC Hui, T Pawson. SH2-containing phosphotyrosine phosphatase as a target of protein-tyrosine kinases. Science 1993; 259:1607-11.
5. Freeman RM, JrJ Plutzky, BG Neel. Identification of a human src homology 2-containing protein-tyrosine-phosphatase: a putative homolog of Drosophila corkscrew. Proc Natl Acad Sci USA 1992; 89:11239-43.
6. Ahmad S, D Banville, Z Zhao, EH Fischer, SH Shen. A widely expressed human protein-tyrosine phosphatase containing src homology 2 domains. Proc Natl Acad Sci USA 1993; 90:2197-201.
7. Vogel W, R Lammers, J Huang, A Ullrich. Activation of a phosphotyrosine phosphatase by tyrosine phosphorylation. Science 1993; 259:1611-4.
8. Adachi M, M Sekiya, T Miyachi, K Matsuno, Y Hinoda, K Imai, A Yachi. Molecular cloning of a novel protein-tyrosine phosphatase SH-PTP3 with sequence similarity to the src-homology region 2. FEBS Lett 1992; 314:335-9.
9. Adachi M, EH Fischer, J Ihle, et al. Mammalian SH2-containing protein tyrosine phosphatases. Cell 1996; 85:15.
10. Yi T, JL Cleveland, JN Ihle. Identification of novel protein tyrosine phosphatases of hematopoietic cells by polymerase chain reaction amplification. Blood 1991; 78:2222-8.
11. Koch CA, D Anderson, MF Moran, C Ellis, T Pawson. SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. Science 1991; 252:668-74.
12. Hof P, S Pluskey, S Dhe-Paganon, MJ Eck, SE Shoelson. Crystal structure of the tyrosine phosphatase SHP-2. Cell 1998; 92:441-50.
13. Eck MJ, S Pluskey, T Trub, SC Harrison, SE Shoelson. Spatial constraints on the recognition of phosphoproteins by the tandem SH2 domains of the phosphatase SH-PTP2. Nature 1996; 379:277-80.
14. Tang TL, RM Freeman, JrAM O'Reilly, BG Neel, SY Sokol. The SH2-containing protein-tyrosine phosphatase SH-PTP2 is required upstream of MAP kinase for early Xenopus development. Cell 1995; 80:473-83.
15. O'Reilly AM and BG Neel. Structural determinants of SHP-2 function and specificity in Xenopus mesoderm induction. Mol Cell Biol 1998; 18:161-77.
16. Neel BG and NK Tonks. Protein tyrosine phosphatases in signal transduction. Curr Opin Cell Biol 1997; 9:193-204.
17. Huyer G and DR Alexander. Immune signalling: SHP-2 docks at multiple ports. Curr Biol 1999; 9:R129-32.
18. Shi ZQ, W Lu, GS Feng. The Shp-2 tyrosine phosphatase has opposite effects in mediating the activation of extracellular signal-regulated and c-Jun NH2-terminal mitogen-activated protein kinases. J Biol Chem 1998; 273:4904-8.
19. Bennett AM, SF Hausdorff, AM O'Reilly, RM Freeman, BG Neel. Multiple requirements for SH-PTP2 in epidermal growth factor-mediated cell cycle progression. Mol Cell Biol 1996; 16:1189-202.
20. Hadari YR, H Kouhara, I Lax, J Schlessinger. Binding of Shp2 tyrosine phosphatase to FRS2 is essential for fibroblast growth factor-induced PC12 cell differentiation. Mol Cell Biol 1998; 18:3966-73.
21. Milarski KL and AR Saltiel. Expression of catalytically inactive Syp phosphatase in 3T3 cells blocks stimulation of mitogen-activated protein kinase by insulin. J Biol Chem 1994; 269:21239-43.
22. Yamauchi K, KL Milarski, AR Saltiel, JE Pessin. Protein-tyrosine-phosphatase SHPTP2 is a required positive effector for insulin downstream signaling. Proc Natl Acad Sci USA 1995; 92:664-8.
23. Inagaki K, T Noguchi, T Matozaki, et al. Roles for the protein tyrosine phosphatase SHP-2 in cytoskeletal organization, cell adhesion and cell migration revealed by overexpression of a dominant negative mutant. Oncogene 2000; 19:75-84.
24. Manes S, E Mira, C Gomez-Mouton, Z J Zhao, RA Lacalle, AC Martinez. Concerted activity of tyrosine phosphatase SHP-2 and focal adhesion kinase in regulation of cell motility. Mol Cell Biol 1999; 19:3125-35.
25. Maegawa H, M Hasegawa, S Sugai, et al. Expression of a dominant negative SHP-2 in transgenic mice induces insulin resistance. J Biol Chem 1999; 274:30236-43.
26. Noguchi T, T Matozaki, K Horita, Y Fujioka, M Kasuga. Role of SH-PTP2, a protein-tyrosine phosphatase with Src homology 2 domains, in insulin-stimulated Ras activation. Mol Cell Biol 1994; 14:6674-82.
27. Allard JD, HC Chang, R Herbst, H McNeill, MA Simon. The SH2-containing tyrosine phosphatase corkscrew is required during signaling by sevenless, Ras1 and Raf. Development 1996; 122:1137-46.
28. You M, DH Yu, GS Feng. Shp-2 tyrosine phosphatase functions as a negative regulator of the interferon-stimulated Jak/STAT pathway. Mol Cell Biol 1999; 19:2416-24.
29. Symes A, N Stahl, SA Reeves, et al. The protein tyrosine phosphatase SHP-2 negatively regulates ciliary neurotrophic factor induction of gene expression. Curr Biol 1997; 7:697-700.
30. Burdon T, C Stracey, I Chambers, J Nichols, A Smith. Suppression of SHP-2 and ERK signalling promotes self-renewal of mouse embryonic stem cells. Dev Biol 1999; 210:30-43.
31. Ohtani T, K Ishihara, T Atsumi, et al. Dissection of signaling cascades through gp130 in vivo: reciprocal roles for STAT3- and SHP2-mediated signals in immune responses. Immunity 2000; 12:95-105.
32. Nicholson SE, DDe Souza, LJ Fabri, J Corbin, TA Willson, JG Zhang, A Silva, M Asimakis, A Farley, AD Nash, D Metcalf, DJ Hilton, NA Nicola, M Baca. Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130. Proc Natl Acad Sci USA 2000; 97:6493-8.
33. Fuhrer DK, GS Feng, YC Yang. Syp associates with gp130 and Janus kinase 2 in response to interleukin-11 in 3T3-L1 mouse preadipocytes. J Biol Chem 1995; 270:24826-30.
34. Tauchi T, GS Feng, MS Marshall, et al. The ubiquitously expressed Syp phosphatase interacts with c-kit and Grb2 in hematopoietic cells. J Biol Chem 1994; 269:25206-11.
35. Tauchi T, GS Feng, R Shen, et al. Involvement of SH2-containing phosphotyrosine phosphatase Syp in erythropoietin receptor signal transduction pathways. J Biol Chem 1995; 270:5631-5.
36. Fujioka Y, T Matozaki, T Noguchi, et al. A novel membrane glycoprotein, SHPS-1, that binds the SH2-domain- containing protein tyrosine phosphatase SHP-2 in response to mitogens and cell adhesion. Mol Cell Biol 1996; 16:6887-99.
37. Zhao ZJ and R Zhao. Purification and cloning of PZR, a binding protein and putative physiological substrate of tyrosine phosphatase SHP-2. J Biol Chem 1998; 273:29367-72.
38. Holgado-Madruga M, DR Emlet, DK Moscatello, AK Godwin, AJ Wong. A Grb2-associated docking protein in EGF- and insulin-receptor signalling. Nature 1996; 379:560-4.
39. Gu H, JC Pratt, SJ Burakoff, BG Neel. Cloning of p97/Gab2, the major SHP2-binding protein in hematopoietic cells, reveals a novel pathway for cytokine-induced gene activation. Mol Cell 1998; 2:729-40.
40. Zhao C, DH Yu, R Shen, GS Feng. Gab2, a new pleckstrin homology domain-containing adapter protein, acts to uncouple signaling from ERK kinase to Elk-1. J Biol Chem 1999; 274:19649-54.
41. Nishida K, Y Yoshida, M Itoh, et al. Gab-family adapter proteins act downstream of cytokine and growth factor receptors and T- and B-cell antigen receptors. Blood 1999; 93:1809-16.
42. Gu H, JD Griffin, BG Neel. Characterization of two SHP- 2- associated binding proteins and potential substrates in hematopoietic cells. J Biol Chem 1997; 272:16421-30.
43. Saxton TM, M Henkemeyer, S Gasca, et al. Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2. Embo J 1997; 16:2352-64.
44. Arrandale JM, A Gore-Willse, S Rocks, et al. Insulin signaling in mice expressing reduced levels of Syp. J Biol Chem 1996; 271:21353-8.
45. Qu CK, WM Yu, B Azzarelli, et al. Biased suppression of hematopoiesis and multiple developmental defects in chimeric mice containing Shp-2 mutant cells. Mol Cell Biol 1998; 18:6075-82.
46. Saxton TM, BG Ciruna, D Holmyard, et al. The SH2 tyrosine phosphatase shp2 is required for mammalian limb development. Nat Genet 2000; 24:420-3.
47. Qu CK, WM Yu, B Azzarelli, GS Feng. Genetic evidence that Shp-2 tyrosine phosphatase is a signal enhancer of the epidermal growth factor receptor in mammals. Proc Natl Acad Sci USA 1999; 96:8528-33.
48. Chen B, RT Bronson, LD Klaman, et al. Mice mutant for Egfr and Shp2 have defective cardiac semilunar valvulogenesis. Nat Genet 2000; 24:296-9.
49. Qu CK, ZQ Shi, R Shen, FY Tsai, SH Orkin, GS Feng. A deletion mutation in the SH2-N domain of Shp-2 severely suppresses hematopoietic cell development. Mol Cell Biol 1997; 17:5499-507.
50. Qu CK and GS Feng. Shp-2 has a positive regulatory role in ES cell differentiation and proliferation. Oncogene 1998; 17:433-9.
51. Kozlowski M, L Larose, F Lee, DM Le, R Rottapel, KA Siminovitch. SHP-1 binds and negatively modulates the c-Kit receptor by interaction with tyrosine 569 in the c-Kit juxtamembrane domain. Mol Cell Biol 1998; 18:2089-99.
52. Yi T, AL Mui, G Krystal, JN Ihle. Hematopoietic cell phosphatase associates with the interleukin-3 (IL-3) receptor beta chain and down-regulates IL-3-induced tyrosine phosphorylation and mitogenesis. Mol Cell Biol 1993; 13:7577-86.
53. Chen HE, S Chang, T Trub, BG Neel. Regulation of colony-stimulating factor 1 receptor signaling by the SH2 domain-containing tyrosine phosphatase SHPTP1. Mol Cell Biol 1996; 16:3685-97.
54. Klingmuller U, U Lorenz, LC Cantley, BG Neel, HF Lodish. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell 1995; 80:729-38.
55. Shultz LD, PA Schweitzer, TV Rajan, et al. Mutations at the murine motheaten locus are within the hematopoietic cell protein -tyrosine phosphatase (Hcph) gene. Cell 1993; 73:1445-54.
56. Shultz LD. Pleiotropic effects of deleterious alleles at the "motheaten" locus. Curr Top Microbiol Immunol 1988; 137:216-22.
57. D'Ambrosio D, KL Hippen, SA Minskoff, et al. Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by Fc gamma RIIB1. Science 1995; 268:293-7.
58. Doody GM, LB Justement, CC Delibrias, et al. A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP. Science 1995; 269:242-4.
59. Wu Y, MJ Nadler, LA Brennan, et al. The B-cell transmembrane protein CD72 binds to and is an in vivo substrate of the protein tyrosine phosphatase SHP-1. Curr Biol 1998; 8:1009-17.
60. Burshtyn DN, AM Scharenberg, N Wagtmann, et al. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. Immunity 1996; 4:77-85.
61. Yu DH, CK Qu, O Henegariu, X Lu, GS Feng. Protein-tyrosine phosphatase Shp-2 regulates cell spreading, igration, and focal adhesion. J Biol Chem 1998; 273:21125-31.
62. Hakak Y, YS Hsu, GS Martin. Shp-2 mediates v-Src-induced morphological changes and activation of the anti-apoptotic protein kinase Akt. Oncogene 2000; 19:3164-71.
63. Tidow N, B Kasper, K Weite. SH2-containing protein tyrosine phosphatases SHP-1 and SHP-2 are dramatically increased at the protein level in neutrophils from patients with severe congenital neutropenia (Kostmann's syndrome). Exp Hematol 1999; 27:1038-45.
64. Bonini JA, J Colca, C Hofmann. Altered expression of insulin signaling components in streptozotocin-treated rats. Biochem Biophys Res Commun 1995; 212:933-8.
65. Ahmad F and BJ Goldstein. Alterations in specific protein-tyrosine phosphatases accompany insulin resistance of streptozotocin diabetes. Am J Physiol 1995; 268:E932-40.